Harmony Biosciences Holdings, Inc. (HRMY)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 15M 30M 45M Q3 '19: 12.9M Q4 '19: 16.8M Q1 '20: 13.3M Q2 '20: 12.4M Q3 '20: 12.6M Q4 '20: 17.5M Q1 '21: 15.5M Q2 '21: 17M Q3 '21: 16.5M Q4 '21: 19.1M Q1 '22: 17.6M Q2 '22: 20.2M Q3 '22: 20.5M Q4 '22: 21.1M Q1 '23: 22.6M Q2 '23: 24.5M Q3 '23: 23.4M Q4 '23: 26.9M Q1 '24: 27.2M Q2 '24: 28.5M Q3 '24: 27.6M Q4 '24: 27.6M Q1 '25: 30.7M Q2 '25: 30.1M Q3 '25: 29.5M Q4 '25: 29.2M Q1 '26: 31.7M Q2 '26: 34.1M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Gross Profit Quarterly

0 70M 140M 210M Q1 '20: 16.4M Q2 '20: 31.5M Q3 '20: 37.7M Q4 '20: 46.4M Q1 '21: 49.3M Q2 '21: 61.1M Q3 '21: 66.1M Q4 '21: 73.4M Q1 '22: 70.6M Q2 '22: 88.1M Q3 '22: 94.2M Q4 '22: 101.4M Q1 '23: 98.3M Q2 '23: 109.2M Q3 '23: 128M Q4 '23: 125.3M Q1 '24: 127.1M Q2 '24: 140.7M Q3 '24: 143.3M Q4 '24: 146.9M Q1 '25: 152.7M Q2 '25: 162.3M Q3 '25: 179.8M Q4 '25: 175.2M Q1 '26: 170.9M Q2 '26: 198.1M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Operating Income Quarterly

-35M 0 35M 70M 105M Q3 '19: -29.8M Q4 '19: -33.7M Q1 '20: -9.6M Q2 '20: 7.3M Q3 '20: 10.4M Q4 '20: 7.8M Q1 '21: 14.5M Q2 '21: 23.3M Q3 '21: 21.1M Q4 '21: 28.6M Q1 '22: 27.6M Q2 '22: 33.1M Q3 '22: 11.9M Q4 '22: 47.6M Q1 '23: 40.4M Q2 '23: 46.9M Q3 '23: 64.5M Q4 '23: 40.2M Q1 '24: 52M Q2 '24: 21.4M Q3 '24: 61.7M Q4 '24: 55.7M Q1 '25: 56.2M Q2 '25: 48.2M Q3 '25: 65.5M Q4 '25: 38.6M Q1 '26: 37.3M Q2 '26: 89.3M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Net Income Quarterly

-60M -30M 0 30M 60M 90M Q3 '19: -31.9M Q4 '19: -36.4M Q1 '20: -38.6M Q2 '20: -27K Q3 '20: 1.9M Q4 '20: -208K Q1 '21: 7.4M Q2 '21: 14.1M Q3 '21: -9.6M Q4 '21: 22.7M Q1 '22: 21.5M Q2 '22: 23.5M Q3 '22: 87.9M Q4 '22: 48.5M Q1 '23: 29.5M Q2 '23: 34.3M Q3 '23: 38.5M Q4 '23: 26.6M Q1 '24: 38.3M Q2 '24: 11.6M Q3 '24: 46.1M Q4 '24: 49.5M Q1 '25: 45.6M Q2 '25: 39.8M Q3 '25: 50.9M Q4 '25: 22.5M Q1 '26: 32.5M Q2 '26: 75.4M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Cost of Revenue Quarterly

0 25M 50M 75M Q1 '20: 3.5M Q2 '20: 6.5M Q3 '20: 7.9M Q4 '20: 9.9M Q1 '21: 10.4M Q2 '21: 12.7M Q3 '21: 14.6M Q4 '21: 17.8M Q1 '22: 14.7M Q2 '22: 18.9M Q3 '22: 23M Q4 '22: 26.9M Q1 '23: 20.8M Q2 '23: 25M Q3 '23: 32.3M Q4 '23: 43.2M Q1 '24: 27.5M Q2 '24: 32.1M Q3 '24: 42.8M Q4 '24: 54.4M Q1 '25: 32M Q2 '25: 38.2M Q3 '25: 59.6M Q4 '25: 68.5M Q1 '26: 44.5M Q2 '26: 63.2M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Operating Cash Flow Quarterly

-50M 0 50M 100M 150M Q4 '19: -24M Q1 '20: -26.7M Q2 '20: 4.8M Q3 '20: 8.8M Q4 '20: 10M Q1 '21: 12.5M Q2 '21: 18.1M Q3 '21: 30.4M Q4 '21: 37.5M Q1 '22: 28.9M Q2 '22: 33.7M Q3 '22: 55.2M Q4 '22: 26.7M Q1 '23: 42.6M Q2 '23: 37.1M Q3 '23: 63.1M Q4 '23: 76.7M Q1 '24: 31.1M Q2 '24: 42.6M Q3 '24: 70.5M Q4 '24: 75.6M Q1 '25: 34M Q2 '25: 79.3M Q3 '25: 108.7M Q4 '25: 126.2M Q1 '26: 27.8M Q2 '26: 92.4M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Free Cash Flow Quarterly

-50M 0 50M 100M 150M Q4 '19: -24M Q3 '20: 8.8M Q4 '20: 10M Q1 '21: 12.5M Q2 '21: 17.9M Q3 '21: 30.3M Q4 '21: 37.5M Q1 '22: 28.8M Q2 '22: 33.7M Q3 '22: 55.1M Q4 '22: 26.7M Q3 '23: 63.1M Q4 '23: 76.6M Q1 '24: 31.1M Q2 '24: 42M Q3 '24: 70.5M Q4 '24: 75M Q1 '25: 33.9M Q2 '25: 79.3M Q3 '25: 108.7M Q4 '25: 126M Q4 '20 Q3 '21 Q2 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 25M 50M 75M Q3 '19: 7.8M Q1 '20: 7.8M Q2 '20: 7.8M Q3 '20: 30.2M Q1 '21: 58.8M Q2 '21: 58.6M Q3 '21: 57.7M Q1 '22: 60.6M Q2 '22: 60.9M Q3 '22: 61.2M Q1 '23: 61.2M Q2 '23: 60.7M Q3 '23: 60.7M Q1 '24: 57.6M Q2 '24: 57.5M Q3 '24: 58.1M Q1 '25: 58.5M Q2 '25: 58.4M Q3 '25: 58.7M Q1 '26: 58.8M Q2 '26: 58.8M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 2.00 4.00 6.00 Q2 '21: 5.53 Q3 '21: 5.50 Q4 '21: 0.58 Q1 '22: 0.80 Q2 '22: 0.95 Q3 '22: 2.56 Q4 '22: 2.97 Q1 '23: 3.10 Q2 '23: 3.27 Q3 '23: 2.46 Q4 '23: 2.12 Q1 '24: 2.31 Q2 '24: 1.95 Q3 '24: 2.11 Q4 '24: 2.51 Q1 '25: 2.62 Q2 '25: 3.10 Q3 '25: 3.18 Q4 '25: 2.72 Q1 '26: 2.49 Q2 '26: 3.09 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.